Powered by Smartsupp

Probiotics, CFU and microencapsulation: understanding labels and studies

KINGRAY ACADEMY · DIGESTION AND GUT HEALTH · 03

What does CFU mean, and why do probiotic strains matter?

CFU describes units able to form colonies under specified conditions. A strain identifies a particular microbial lineage. A high CFU count or microencapsulation alone does not demonstrate a health benefit. [1] [3] [5]

We explain live and inactivated cultures, microencapsulation, study types and the questions that help establish what a finding actually shows.

Author: Ing. František Kokoš – nutrition adviserPublished: Updated:

01 · Bacterial species and strains: why identification matters

KINGRAY Academy

A species is a group of related microorganisms. A strain is a specific lineage within a species. In scientific names, the species name may be followed by a strain code.

When researchers investigate a particular strain, a matching species name alone is not enough to attribute the same finding to all other strains. Compare the full designation, the dose studied and the specific outcome. How far findings can be generalised depends on the nature of the evidence. [1]

Illustrative example: A study investigated “species A, strain X”. Another preparation lists only “species A” on its label. Without the strain code, it is not possible to confirm that it contains the same strain that was tested.

The scientific definition of a probiotic includes live microorganisms, an adequate amount and a demonstrated health benefit. The presence of a bacterial culture alone does not establish that all these conditions are met. [1]

↑ Back to article contents

02 · CFU, cell counts and inactivated microorganisms

CFU stands for colony-forming units. In culture-based testing, it expresses the number of units capable of forming a colony under specified conditions. The result also depends on the method and culture conditions; it is not a universal count of every living cell. [5]

Depending on the method used, the total cell count may include cells that do not form colonies. “Billions of cells” therefore cannot automatically be treated as equivalent to “billions of CFU”.

Inactivated microorganisms have been processed so that they are no longer alive. Preparations containing them are assessed separately. Under the scientific consensus definition, the term “postbiotic” also requires a demonstrated health benefit; not every inactivated culture meets this definition. [2]

What to look for in the documentation: the unit of measurement, the method used, the condition of the cultures after processing and the time point to which the declared amount refers. For live cultures, also ask about data during storage.

↑ Back to article contents

03 · Microencapsulation: a technology that needs testing

Microencapsulation means enclosing material within tiny coating structures. With bacterial cultures, researchers investigate factors such as stability during storage or behaviour under simulated digestive conditions.

Published laboratory research compared different coating materials for Lactobacillus plantarum cultures. Such tests illustrate why both the coating composition and test conditions matter. Findings for one specific technology cannot be applied to all microencapsulated preparations without further data. [3]

Two different outcomes: “More culturable cells remained in a model solution” describes a technology test. “A measured health outcome improved in people” describes a clinical research finding. The first result alone does not demonstrate the second.

↑ Back to article contents

04 · Laboratory experiments, animal models and human studies

The type of study determines which question it can answer. The table provides a general guide; quality must also be assessed in light of the specific methods and limitations.

Research type What it investigates Main limitation
Research typeLaboratory experiment · in vitro What it investigatesThe behaviour of cells or materials under controlled conditions. Main limitationDoes not demonstrate a health outcome in humans.
Research typeAnimal model What it investigatesAn organism’s response within a particular model. Main limitationFindings do not automatically apply to humans.
Research typeObservational study What it investigatesAssociations between observed factors. Main limitationAn association alone does not establish causation.
Research typeRandomised controlled trial What it investigatesAn intervention compared with a control, with participants assigned at random. Main limitationSize, quality, population and measured outcomes all matter.
Research typeSystematic review What it investigatesA combined assessment of available studies using predefined methods. Main limitationThe certainty of the conclusion depends on the quality and consistency of the included evidence.

Assessing the certainty of evidence involves factors such as risk of bias, inconsistency, indirectness and imprecision. Even a review of several studies can therefore lead to an uncertain conclusion. [4]

↑ Back to article contents

05 · When does a finding apply to a specific preparation?

When comparing a study with another preparation, check the strain identities, live or inactivated form, dose, combination of ingredients, route of administration and population studied.

Research on one strain may provide relevant evidence, but it is not automatically a clinical study of every blend containing that strain. You must also consider whether the tested route of administration and measured outcome match the question you want to answer.

Illustrative example: Imagine research on inactivated bacteria in toothpaste that measures markers in saliva. Such an experiment does not directly test the effect of a swallowed liquid preparation on intestinal symptoms.

A useful question is: Did the authors test this preparation, or does the finding concern only a similar ingredient or technology?

[1] [4]

↑ Back to article contents

06 · A practical checklist for reading a study

  1. What was tested? A specific strain, a blend, a finished preparation or a coating material?
  2. In whom or in what? Cells, animals, healthy volunteers or a particular patient group?
  3. What was the comparison? A placebo, another intervention or only the situation before use?
  4. How many people enrolled, and how many completed the study? Also check why participants withdrew.
  5. What were the dose and follow-up period? A short experiment cannot answer every question about long-term use.
  6. What was measured? A laboratory marker, questionnaire responses, symptoms or another predefined outcome?
  7. How large was the difference? Look for absolute values and measures of uncertainty, not just a percentage.
  8. What limitations do the authors report? Also read the funding information, conflicts of interest and safety data.

Manufacturer funding does not by itself invalidate a study. It is, however, part of the context that readers should know. Publication in a peer-reviewed journal does not remove the need to assess the methods and limitations.

[1] [4]

↑ Back to article contents

07 · Percentages, graphs and “statistical significance”

A p-value does not indicate the size of an effect or its practical importance. The label “statistically significant” is therefore not enough. Examine the difference between groups, the confidence interval and the relevance of the measured outcome. [6]

When reading a graph, check the units, axis range, number of observations and explanation of the error bars. For a percentage, ask what its baseline or denominator is and whether there is a control group.

Illustrative example: If a measure decreases from 4 to 3, this is a relative decrease of 25%, but an absolute decrease of one unit. Its practical importance depends on what that unit represents and how the control group changed.

When reviewing evidence, distinguish an effect that has not been demonstrated from convincing evidence that an effect is not practically meaningful. A small or imprecise study may leave the question open. [4]

↑ Back to article contents

In plain language

The number on a label describes quantity, and the technology describes processing. A health outcome requires suitable studies of the specific cultures, doses and uses.

[1] [3] [4]

↑ Back to article contents

Frequently asked questions

Is a higher CFU count automatically better?

No. The count alone is not enough to draw a conclusion about an outcome. The specific cultures, dose studied, form and available evidence matter.

[1]

Are more bacterial strains automatically better?

No. The number of strains describes the composition. A particular blend must be assessed using research relevant to that blend.

[1]

Does microencapsulation prove a health effect?

Not by itself. A technology test of stability or coating behaviour addresses a different question from a health outcome in humans.

[3]

Are inactivated bacteria the same as live cultures?

No. They are different forms, and research findings must be related to the form actually tested.

[2]

Is a patent a clinical study?

No. A patent is a document relating to the protection of an invention. It may contain experimental data, but its existence alone does not demonstrate a clinical effect.

Does a quality certificate confirm efficacy?

Documentation of manufacturing quality or batch analysis answers questions within the scope of that document. It does not replace clinical testing of a specific health outcome.

What is the difference between probiotics, prebiotics and postbiotics?

Probiotics are live microorganisms with a demonstrated benefit when given in adequate amounts. Prebiotics are substrates selectively used by host microorganisms that confer a health benefit. Postbiotics are preparations of inactivated microorganisms or their components with a demonstrated health benefit.

[1] [2] [7]

Scientific references

  1. Hill C. et al. (2014). ISAPP consensus on the definition and use of the term probiotic. Nature Reviews Gastroenterology & Hepatology. Open publication.
  2. Salminen S. et al. (2021). ISAPP consensus on the definition and scope of postbiotics. Nature Reviews Gastroenterology & Hepatology. Open publication and correction links.
  3. Survivability of alginate-microencapsulated Lactobacillus plantarum during storage, simulated food processing and gastrointestinal conditions (2020). Experimental research on a technology; not a clinical study in humans. Open publication.
  4. Cochrane Handbook, Chapter 14: assessing the certainty of evidence and summary of findings tables. Open methods guidance.
  5. FDA, Bacteriological Analytical Manual, Chapter 3: Aerobic Plate Count. A methodological source on culture-based counting; not a validation protocol for every specific bacterial preparation. Open methods guidance.
  6. Wasserstein R. L., Lazar N. A. (2016). The ASA Statement on p-Values: Context, Process, and Purpose. The American Statistician. Open statement. · ASA · PDF
  7. NCCIH: Probiotics — Usefulness and Safety

This article explains the principles of evaluating research. It does not constitute clinical validation of a specific product or individual treatment advice.

Ing. František Kokoš
Author: Ing. František Kokoš
Ing. František Kokoš – Author of KINGRAY Academy and Advice Corner
Technician, nutrition adviser (graduate of the 150-hour Welko retraining programme, 2025) and creator of the KINGRAY nutraceuticals concept. Years of developing the BIOquant medical device and working with blood rheology and tissue oxygenation led him to realise that bodily health requires the full picture – linking microcirculation, cellular energy and proper nutrition. In his articles, he looks for the balance where the body understands and cooperates with us.
He is the author of the book Liečba svetlom (Light Therapy, ISBN 978-80-970512-0-4), co-author of the publication BIOquant – polovodičová laserová terapia (BIOquant – Semiconductor Laser Therapy, ISBN 978-80-970512-2-8), and originator of patents in light technologies (US9731145B2, SK5457Y1).
%s ...
%s
%image %title %code %s
%s